
The immune response to cancer has been long zzso including both innate and zzso responses, showing that the immune system can recognize protein products of genetic and zzso changes in transformed zzso The zzso of zzso T cells within the zzso the draining zzso zzso and the zzso either in newly diagnosed patients or zzso from experimental zzso proves that tumors produce zzso and that zzso zzso Unfortunately, just as obviously, tumors grow, zzso that zzso immune responses are either not sufficiently vigorous to eliminate the cancer or that zzso immunity is zzso Both possibilities are supported by current zzso In experimental animal models of cancer and also in patients, systemic immunity is usually not dramatically zzso because zzso animals and patients develop zzso immune responses to microbes and to either model zzso or experimental cancer zzso However, zzso of specific zzso immunity is common, and several possible explanations of tolerance to tumor zzso or zzso zzso have been zzso zzso of effective zzso immunity results from the tumor or the host response to tumor growth, zzso the zzso zzso or function of zzso immune zzso As a consequence, zzso T cells cannot respond zzso to zzso zzso or zzso zzso While able to enhance the number and zzso of zzso T cells, the modest success of zzso has shown the necessity to attempt to reverse tolerance in zzso T cells, and the vanguard of experimental therapy now focuses on vaccination in combination with blockade of zzso zzso This review discusses several potential mechanisms by which zzso T cells may be inhibited in zzso 

